Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients

Diabetes Care

Volumn 23, Issue SUPPL. 2, 2000, Pages

  Shichiri, Motoaki ^a   Kishikawa, Hideki ^a   Ohkubo, Yasuo ^a   Wake, Nakayasu ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COHORT ANALYSIS; CONFERENCE PAPER; CONTROL SYSTEM; DIABETES CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; JAPAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PRIMARY PREVENTION; SURVIVAL TIME;

ADULT; ALBUMINURIA; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPOGLYCEMIA; INJECTIONS; INSULIN; LIPIDS; MALE; MIDDLE AGED; PERIPHERAL NERVES; WEIGHT GAIN;

EID: 0034071036     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329:977-986, 1993
3. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T: Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164-170, 1991
4. The Kroc Collaborative Study Group: Diabetic retinopathy after two years of intensified insulin treatment. JAMA 260:37-41, 1988
5. Brinchmann-Hansen O, Dahl-Jørgensen K, Sandvik L, Hanssen KF: Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 304:19-22, 1992
6. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
7. Service FJ, Molner GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644-655, 1970
8. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 177:95-102, 1965
9. Early Treatment Diabetic Retinopathy Study Research Group: Early Treatment Diabetic Retinopathy Study: Manual of Operations. Bethesda, MD, Public Health Service, 1980
10. Early Treatment Diabetic Retinopathy Study Research Group: ETDRS report no. 10: grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. Ophthalmology 98:786-806, 1991
11. Early Treatment Diabetic Retinopathy Study Research Group: ETDRS report no 12: fundus photographic risk factors for progression of diabetic retinopathy. Ophthalmology 98:823-833, 1991
12. Mogensen CE: Management of diabetic renal involvement and disease. Lancet ii:867-870, 1988
13. lc Determination, the Japan Diabetes Society. J Jpn Diabetes Soc 37:233-243, 1994
14. Lee ET: Statiatiscal Method for Survival Data Analysis. Belmont, CA, Lifetime Learning Publications, 1981
15. Kishikawa H, Hashimoto Y, Hashiguchi Y, Sasahara T, Nishiyama T, Yano T, Yamaguchi K, Shichiri M: Insulin treatment regimes tor type II (non-insulin dependent) diabetes mellitus as judged by residual B-cell function. Diabetes Nutr Metab 4:305-312, 1991
16. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:817-853, 1998
17. U.K. Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
18. U.K. Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713, 1998
19. lc) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
20. Shigeta Y, Haneda M, Kikkawa R: Early detection and progression of nephropathy in patients with non-insulin-dependent diabetes. In Prevention and Treatment of NIDDM. Goto Y, Lee TH, Kaneko T, Shigeta Y, Eds. London, Smith-Gordon, 1992, p. 289-291
21. Kuzuya K, Akanuma Y, Akazawa Y, Uehata T: Prevalence of chronic complications in Japanese diabetic patients. Diabetes Res Clin Pract 24 (Suppl.):S159-S164, 1994
22. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindhlad LEL, Jensen-Urstad MT: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45:1253-1258, 1996
23. The DCCT Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90: 450-459, 1991
24. Shichiri M, Kishikawa H: Insulin treatment of non-insulin-dependent diabetes mellitus: strict glycemic control and its effect on insulin sensitivity. In Prevention and Treatment of NIDDM. Goto Y, Lee TH, Kaneko T, Shigeta Y, Eds. London, Smith-Gordon, 1992, p. 459-463
25. The Diabetes Control and Complications Trial Research Group: Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11:567-573, 1988